About: covid:2b16defcc0489b49c7b1a5554c2effb8ebd2ca68

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:2b16defcc0489b49c7b1a5554c2effb8ebd2ca68 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Fischer, André Neranjan, Santhosh Sellner, Manuel Smieško, Martin Lill, Markus
is schema:about of	named entity 'virus' named entity 'patients' named entity 'advise' named entity 'potential' named entity 'number' named entity 'binding energies' named entity 'shape' named entity 'ligand' named entity 'epidemic' named entity 'evaluated' named entity 'pro' named entity 'PATIENTS' named entity 'POTENTIAL' named entity 'COMPOUND LIBRARY' named entity 'CAUSED' named entity 'LIST' named entity 'THERAPEUTICS' named entity 'conventional' named entity 'relation' named entity 'pro' named entity 'After' named entity 'list' named entity 'compounds' named entity 'therapeutic intervention' named entity 'inhibition' named entity 'antiviral' named entity 'compound library' named entity 'proteases' named entity 'peptidomimetic' named entity 'Inhibitors' named entity 'binding affinity' named entity 'compound library' named entity 'Rhamnetin' named entity 'crystal structure' named entity 'chemical space' named entity 'proteolytic processing' named entity 'ligand binding' named entity 'antiviral' named entity 'peptidomimetic' named entity 'SARS-CoV-2' named entity 'Virtual Screening' named entity 'therapeutics' named entity 'peptidomimetics' named entity 'proteases' named entity 'PSA' named entity 'GBSA' named entity 'drug repurposing' named entity 'PSA' named entity 'Virtual Screening' named entity 'ligand binding' named entity 'ZINC database' named entity 'pharmacokinetic' named entity 'peptidomimetics' named entity 'oral bioavailability' named entity 'SARS-CoV-2' named entity 'pharmacokinetic' named entity 'metabolic stability' named entity 'free energy' named entity 'molecular weight' named entity 'crystal structures' named entity 'Virtual screening' named entity 'peptides' named entity 'PDB' named entity 'crystal structures' named entity 'PDB' named entity 'molecular weight' named entity 'ligand' named entity 'protein structure' named entity 'Crystal structures' named entity 'ligands' named entity 'ligand' named entity 'Pharmacokinetic' named entity 'distribution coefficient' named entity 'logD' named entity 'Virtual screening' named entity 'catalytic function' named entity 'peptides' named entity 'polar surface area' named entity 'enzyme' named entity 'proteases' named entity 'antiviral drugs' named entity 'protease' named entity 'molecular dynamics' named entity 'China' named entity 'protease' named entity 'SARS-CoV-2' named entity 'drug repurposing' named entity 'vaccines' named entity 'SARS-CoV-1' named entity 'development' named entity 'binding' named entity 'drugs' named entity 'order' named entity 'narrow' named entity 'MOLECULAR'

Attributes

Values

Creator

Fischer, André
Neranjan, Santhosh
Sellner, Manuel
Smieško, Martin
Lill, Markus

is schema:about of

named entity 'virus'
named entity 'patients'
named entity 'advise'
named entity 'potential'
named entity 'number'
named entity 'binding energies'
named entity 'shape'
named entity 'ligand'
named entity 'epidemic'
named entity 'evaluated'
named entity 'pro'
named entity 'PATIENTS'
named entity 'POTENTIAL'
named entity 'COMPOUND LIBRARY'
named entity 'CAUSED'
named entity 'LIST'
named entity 'THERAPEUTICS'
named entity 'conventional'
named entity 'relation'
named entity 'pro'
named entity 'After'
named entity 'list'
named entity 'compounds'
named entity 'therapeutic intervention'
named entity 'inhibition'
named entity 'antiviral'
named entity 'compound library'
named entity 'proteases'
named entity 'peptidomimetic'
named entity 'Inhibitors'
named entity 'binding affinity'
named entity 'compound library'
named entity 'Rhamnetin'
named entity 'crystal structure'
named entity 'chemical space'
named entity 'proteolytic processing'
named entity 'ligand binding'
named entity 'antiviral'
named entity 'peptidomimetic'
named entity 'SARS-CoV-2'
named entity 'Virtual Screening'
named entity 'therapeutics'
named entity 'peptidomimetics'
named entity 'proteases'
named entity 'PSA'
named entity 'GBSA'
named entity 'drug repurposing'
named entity 'PSA'
named entity 'Virtual Screening'
named entity 'ligand binding'
named entity 'ZINC database'
named entity 'pharmacokinetic'
named entity 'peptidomimetics'
named entity 'oral bioavailability'
named entity 'SARS-CoV-2'
named entity 'pharmacokinetic'
named entity 'metabolic stability'
named entity 'free energy'
named entity 'molecular weight'
named entity 'crystal structures'
named entity 'Virtual screening'
named entity 'peptides'
named entity 'PDB'
named entity 'crystal structures'
named entity 'PDB'
named entity 'molecular weight'
named entity 'ligand'
named entity 'protein structure'
named entity 'Crystal structures'
named entity 'ligands'
named entity 'ligand'
named entity 'Pharmacokinetic'
named entity 'distribution coefficient'
named entity 'logD'
named entity 'Virtual screening'
named entity 'catalytic function'
named entity 'peptides'
named entity 'polar surface area'
named entity 'enzyme'
named entity 'proteases'
named entity 'antiviral drugs'
named entity 'protease'
named entity 'molecular dynamics'
named entity 'China'
named entity 'protease'
named entity 'SARS-CoV-2'
named entity 'drug repurposing'
named entity 'vaccines'
named entity 'SARS-CoV-1'
named entity 'development'
named entity 'binding'
named entity 'drugs'
named entity 'order'
named entity 'narrow'
named entity 'MOLECULAR'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software